MANGROVE PARTNERS IM, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MANGROVE PARTNERS IM, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$8,892,000
-2.3%
1,092,394
+15.2%
1.12%
-49.4%
Q2 2020$9,099,000
+95.7%
947,852
+38.6%
2.22%
+246.5%
Q1 2020$4,650,000
-63.2%
683,828
-19.3%
0.64%
-65.3%
Q4 2019$12,625,000
+45.4%
847,2840.0%1.85%
+75.7%
Q3 2019$8,685,000
-3.3%
847,2840.0%1.05%
+3.6%
Q2 2019$8,981,000
+17.4%
847,284
+54.8%
1.02%
-0.8%
Q1 2019$7,651,000
+37.6%
547,2840.0%1.02%
+38.1%
Q4 2018$5,560,000547,2840.74%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders